Manufacturers' warranty for drug products
Roffe, B.D.; Solomon, D.K.
American Journal of Hospital Pharmacy 39(9): 1456-1457
1982
ISSN/ISBN: 0002-9289 PMID: 7137179 Document Number: 185357
Document emailed within 1 workday
Related Documents
Mascoli, C.C.; Weary, M.E. 1979: Limulus amebocyte lysate (LAL) test for detecting pyrogens in parenteral injectable products and medical devices: advantages to manufacturers and regulatory officials Journal of the Parenteral Drug Association 33(2): 81-95Pickens, A. 1978: Mary Carter agreements and disclosure by drug manufacturers Texas Medicine 74(10): 27-28
Yang, Y-Yin.; Dong, Z.; Xia, Y-Peng. 2012: Discussion on adverse reactions monitoring modes of drug manufacturers under new measures for administration of adverse drug reaction report and monitoring Zhongguo Zhong Yao Za Zhi 37(21): 3329-3333
Olesen, F. 2013: The simple, the difficult and the obvious--about the opportunities and pitfalls of the diagnostic warranty Ugeskrift for Laeger 175(39): 2292-2293
Knapp, D.E.; Crosby, D.L.; Brandon, B.M.; Knapp, D.A. 1978: Can pharmacists influence drug prescribing? a look at eight of the top 25 drug products for 1976 American Journal of Hospital Pharmacy 35(5): 593-594
Hu, L-hong.; Xu, J-qing. 2009: Drug discovery based on classic natural products Yao Xue Xue Bao 44(1): 11-18
Panettieri, A.J.; Williams, W.T. 1972: Rejection rate of reconstituted injectable drug products American Journal of Hospital Pharmacy 29(4): 294-295
Ward, T.S.; Jablonski, H.I.; Vanantwerp, J. 1992: Drug use evaluation of acetaminophen-containing products at a community hospital Hospital Formulary 27(9): 947
Rüsing, D.; Bauer, K.; Verspohl, E.J. 2004: Drug and medicinal products for the consumer. a critical evaluation Medizinische Monatsschrift für Pharmazeuten 27(3): 84-91
Dev, S. 2010: Impact of natural products in modern drug development Indian Journal of Experimental Biology 48(3): 191-198
Dahlin, P.A.; Paredes, S.M. 1980: Visual compatibility of dobutamine with seven parenteral drug products American Journal of Hospital Pharmacy 37(4): 460; 464
Fritsch, O.; Gueinzius, E. 1972: Application of economic agreements relating to drug products Pharmazeutische Praxis 9(Suppl 9): 199-120
Cramer, R. 1985: Assistance from community pharmacists in identifying generic drug products American Journal of Hospital Pharmacy 42(9): 1936; 1938
Zimmerman, P.F.; Larsen, R.K.; Barkley, E.W.; Gallelli, J.F. 1981: Recommendations for the safe handling of injectable antineoplastic drug products American Journal of Hospital Pharmacy 38(11): 1693-1695
Knoben, J.E.; Scott, G.R.; Tonelli, R.J. 1990: An overview of the FDA publication Approved Drug Products with Therapeutic Equivalence Evaluations American Journal of Hospital Pharmacy 47(12): 2696-2700
1994: For U.S. drug companies' products sold in developing countries, labeling is often inadequate American Journal of Hospital Pharmacy 51(7): 875-876
Wolfert, R.R.; Cox, R.M. 1975: Room temperature stability of drug products labeled for refrigerated storage American Journal of Hospital Pharmacy 32(6): 585-587
Binder, P. 1994: Can the general practitioner care for outpatient drug addicts without substitution treatments? what products can he use? Annales de Medecine Interne 145(Suppl 3): 62-64
Blankenship, C.E. 2014: Final guidance for pharmacy compounding of human drug products under Section 503A International Journal of Pharmaceutical Compounding 18(5): 379-380
Hemanth Kumar, A.K.; Sudha, V.; Swaminathan, S.; Ramachandran, G. 2010: Comparison of HPLC and spectrophotometric methods for estimation of antiretroviral drug content in pharmaceutical products Indian Journal of Medical Research 132: 390-394